Assessing the Acute Effects of Diagonal Mobilization (Manual Therapy)

February 22, 2025 updated by: Medical University of Gdansk

ASSESSING the ACUTE EFFECTS of DIAGONAL MOBILIZATION on STATIC and DYNAMIC BALANCE in YOUNG FOOTBALL PLAYERS: a RANDOMIZED DOUBLE-BLIND STUDY

Investigating the acute effects of mobilization on these parameters offers innovative insights for the practitioner community and sheds light on the strategy's potential effectiveness in mitigating injury risk. Therefore, this study aims to assess the immediate effects of mobilization on static and dynamic balance in young male and female soccer players using a randomized, double-blinded study design.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

Participants underwent assessment twice: once before the intervention and again afterward. Tests included the single leg lend and hold test and the single leg standing test, measured using force plates.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Poland
      • Gdańsk, Poland, 80-210
        • AZS Central Academic Sports Center in Gdańsk

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • age between 14 to 16 years old, with regular soccer practice;
  • absence of lower limb and lumbar spine surgery or injuries within the last 6 months (hip, knee, ankle), no current pain in the hip, knee, or ankle joints, no hypermobility of the lower limb joints, and no history of neurological or connective tissue disorders;
  • availability for both assessment time points

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Assessing the acute effects of mobilization
Participants will undergo an active intervention consisting of passive mobilization of rhythmic gliding.
Other: Placebo
Placebo intervention; the therapy will mimic exceptional mobilization.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Single leg standing
Time Frame: 2-3 seconds
Participants will initiate the evaluation by standing on force plates (ForceDecks, VALD, Brisbane, Australia) in a standard standing posture.
2-3 seconds

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Medical University of Gdansk

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 25, 2025

Primary Completion (Estimated)

December 31, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

November 30, 2024

First Submitted That Met QC Criteria

December 4, 2024

First Posted (Actual)

December 6, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 22, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • KB/392/2023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aged 14 to 16

Clinical Trials on Placebo

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe